What To Know: FDA Approves Apomorphine for Parkinson Disease
Drug Topics
FEBRUARY 10, 2025
Expert highlights the benefits of using apomorphine infusion to provide more consistent medication levels and reduce the unpredictable fluctuations.
Sat.Feb 08, 2025 - Fri.Feb 14, 2025
459 
Antibiotic Minimum Inhibitory Concentrations: Do You know These 6 Things About Them?
IDStewardship
FEBRUARY 12, 2025
In this article an infectious diseases pharmacist discusses important information to know about antibiotic minimum inhibitory concentrations. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted12 February 2024 An antibiotic’s minimum inhibitory concentrations (MIC) is the lowest drugconcentration that prevents visible growth of a standard inoculum of a microorganism after ~24 hours of incubation.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opinion: How to close America’s life expectancy gap
STAT
FEBRUARY 13, 2025
It’s no secret that life expectancy in the United States is among the lowest in the developed world and has been since long before the Covid-19 pandemic. The United States ranked 29 th in life expectancy at birth among peer nations in the Organization for Economic Cooperation and Development despite spending almost twice as much on clinical care per person as the average OECD nation.
The kids are alright: How pharma can make inroads with Gen Z
PharmaVoice
FEBRUARY 12, 2025
As drug development priorities shift, pharma companies need to understand younger patients to improve their reputation.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
In My View: Vigilant Citizens Should Be Celebrated, Not Vilified
Drug Topics
FEBRUARY 12, 2025
Those who contributed to the arrest of Luigi Mangione, the suspect in the murder of UnitedHealthcare CEO Brian Thompson, are facing unjustified backlash. They are heroesnot snitches.
Guest Perspective: Prioritize Innovative Care
PhRMA
FEBRUARY 11, 2025
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Salesforce or Veeva: How drugmakers can navigate the upcoming CRM split
PharmaVoice
FEBRUARY 13, 2025
The two companies will let their long-running contract expire this year, and drugmakers will need to decide which is the best platform for them in a changing marketplace.
Q&A: How Barbershops Are Transforming Hypertension Management
Drug Topics
FEBRUARY 12, 2025
Crystal Zhou, PharmD, APh, AHSCP, BCACP, discussed her role as Lead Pharmacist of the Cut Hypertension Program.
Reducing Costs with Medication Reconciliation: PharmD Live’s Proven Approach to Better Outcomes
PharmD Live
FEBRUARY 12, 2025
As healthcare shifts toward value-based care, medication reconciliation has become a critical focus for reducing costs and improving patient outcomes. Discrepancies in medication regimens, particularly during care transitions like hospital discharge, are a leading cause of adverse drug events (ADEs). These preventable issues result in significant financial burdens on healthcare systems while compromising patient safety and care quality.
STAT+: With $40 million, former DeepMind employees launch startup ‘laser-focused’ on AI protein design
STAT
FEBRUARY 12, 2025
Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem. In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. But Isomorphic’s initial focus is on small-molecule drug discovery, with protein-based drugs remaining a distant twinkle in the company’s eye.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
In the crowded cardio space, it’s David vs. Goliath for small biotechs
PharmaVoice
FEBRUARY 11, 2025
What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.
Weight Loss, Lipid Changes Could Point Towards Dementia Risk
Drug Topics
FEBRUARY 11, 2025
Poor cardiometabolic health is associated with cognitive impairment in later life, but there is no clear association between cardiometabolic trajectories and early markers.
From Menarche to Post Menopause: The Vital Role of Pharmacists in Women’s Health
Pharmacy Times
FEBRUARY 13, 2025
Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.
STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
STAT
FEBRUARY 14, 2025
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. And the move comes after Moderna was chastised for the second time in five months by a U.K. trade group over its attempts to recruit children into a late-stage clinical trial for its Covid shot.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments
PharmaVoice
FEBRUARY 10, 2025
Fractyl Health is entering pivotal studies for a procedure that aims to be an ‘off ramp’ to GLP-1s and exploring how a one-time, ‘smart GLP-1’ gene therapy can Treat type 2 diabetes.
Healthy Cardiovascular System Associated with Increased Migraine Incidence
Drug Topics
FEBRUARY 12, 2025
Cardiovascular health is known to be associated with the probability of having active or developing migraine in the future.
The real cost of denying access to medicines in Medicaid
PhRMA
FEBRUARY 12, 2025
Policies to contain health care costs by restricting access to medicines always come with the promise of making health care more affordable and reducing government spending. But what if they’re actually doing the opposite? A new study published in JAMA on Medicaid prescription denials exposes a harsh reality: denying access to medications doesn’t save Medicaid money, it’s shifting costs in a way that hurts both patients and taxpayers.
STAT+: Corbus reports first Western data for closely tracked ADC cancer drug
STAT
FEBRUARY 14, 2025
Corbus Pharmaceuticals on Friday presented new data from the first Western study of its antibody-drug conjugate treatment for cancer that largely mirrored previous results reported from China. In a study conducted in the U.S. and the U.K., the Corbus drug, called CRB-701, showed an overall response rate of 27% from 26 evaluable patients with nine different types of cancer — all in advanced stages.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Are orexins the next golden child of neuroscience?
PharmaVoice
FEBRUARY 10, 2025
An emerging class of orexin-based drugs are on the cusp of disrupting care for sleep disorders — and potentially much more.
Male Patients With Diabetes, Obesity Have Poorer Prognosis of Thyroid Cancer
Drug Topics
FEBRUARY 12, 2025
Recently, there has been concern around glucagon-like peptide-1 receptor agonists and increase the risk of thyroid cancer, with liraglutide having a black box warning label for the disease.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 14, 2025
Editor's Note: This is a developing story. If you are a dismissed or active federal worker with information to share, please reach out at ntong@questex.com. | The federal government is laying off thousands of health agency workers and others this week. Here's what we know so far.
The view from overseas on tumult in U.S. science
STAT
FEBRUARY 14, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe’s reaction to talk of an academic brain drain in the U.S., and more.
FDA Accepts BLA for Lerodalcibep, a Novel Agent to Lower LDL-Cholesterol in Atherosclerotic Cardiovascular Disease
Pharmacy Times
FEBRUARY 13, 2025
The agency will now review the novel PCSK9 inhibitor for possible approval in patients with or at high risk of atherosclerotic cardiovascular disease.
Adults with Chronic Pain Support Cannabis Use More Than Physicians
Drug Topics
FEBRUARY 10, 2025
Researchers asked adults with chronic pain and physicians their opinions on cannabis regulations.
EU Urban Wastewater Treatment Directive may compromise EU medicine availability
European Pharmaceutical Review
FEBRUARY 13, 2025
New analysis by VTT Technical Research Centre of Finland has highlighted the EUs completely underestimated costs of the newly enforced Urban Wastewater Treatment Directive. Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 13, 2025
Immediately following Senate confirmation, Robert F. Kennedy Jr. has been named chair of the Make America Healthy Again Commission, which will be focused on chronic disease and transparency in medical research.
Pharmacists Educate and Bridge Communication Gaps for Patients With Pericarditis
Pharmacy Times
FEBRUARY 14, 2025
Pharmacists can help educate patients, identify adverse events, and help patients communicate with other health care professionals or drug companies.
FDA Grants Fast Track Designation to Cannabis Withdrawal Syndrome Therapy
Drug Topics
FEBRUARY 13, 2025
A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.
CMS, don’t fall behind the rest of the medical community on obesity
PhRMA
FEBRUARY 13, 2025
PhRMA recently submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) proposed rule which would extend coverage of anti-obesity medicines (AOMs) in Medicare Part D and state Medicaid plans. Currently, AOMs are excluded from Medicare Part D coverage and optional in state Medicaid programs, when used specifically for the treatment of obesity, because they’re labeled as “agents used for weight loss.
Can you take meloxicam for tooth pain?
The Checkup by Singlecare
FEBRUARY 11, 2025
Meloxicam , sold under the brand name Mobic, is a prescription nonsteroidal anti-inflammatory drug ( NSAID ) used to treat inflammatory conditions like rheumatoid arthritis and osteoarthritis. It is also used off-label (for a use not approved by the Food and Drug Administration) to treat ankylosing spondylitis. Meloxicam is a stronger painkiller than other NSAIDs like ibuprofen and naproxen.
Bridging Evidence Gaps: The Expanding Role of Real-World Evidence in Regulatory and HTA Decision-Making
Pharmacy Times
FEBRUARY 13, 2025
The expanding role of real-world evidence in regulatory and health technology assessment (HTA) decision-making highlights its growing acceptance for supplementing clinical trial data, addressing evidence gaps, and informing treatment value, despite challenges in data quality, accessibility, and regulatory compliance.
FDA Approves Merilog as Biosimilar to Insulin Aspart for Diabetes
Drug Topics
FEBRUARY 14, 2025
The drug is the first rapid-acting insulin biosimilar product approved for use by the FDA, marking a significant milestone in diabetes treatment.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 14, 2025
The dismissals will free up over $98 million annually which will be redirected to veterans' care, benefits and services, the department said. The cuts are part of the White House's broader directive to slash federal workforces.
Let's personalize your content